No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study-Reference-Cited by-同舟云学术

No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study

Published:2024-04-26 Issue: Volume: Page:
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Ayano Masahiro^ORCID,Hirata Akie^ORCID,Tokunaga Shoji^ORCID,Furuhashi Hiroko^ORCID,Kimoto Yasutaka^ORCID,Ono Nobuyuki^ORCID,Arinobu Yojiro^ORCID,Nakashima Naoki^ORCID,Akashi Koichi^ORCID,Horiuchi Takahiko^ORCID,Niiro Hiroaki^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00296-024-05593-6.pdf

Reference30 articles.

1. Fanouriakis A, Tziolos N, Bertsias G et al (2021) Update in the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80:14–25. https://doi.org/10.1136/annrheumdis-2020-218272

2. Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393:2344–2358. https://doi.org/10.1016/s0140-6736(19)30546-x

3. Fanouriakis A, Kostopoulou M, Andersen J et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83:15–29. https://doi.org/10.1136/ard-2023-224762

4. Van Vollenhoven RF, Mosca M, Bertsias G et al (2014) Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 73:958–967. https://doi.org/10.1136/annrheumdis-2013-205139

5. Mok CC, Hamijoyo L, Kasitanon N et al (2021) The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus. Lancet Rheumatol 3:e517-531. https://doi.org/10.1016/S2665-9913(21)00009-6